T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2B |
| 2 |
Sea Limited
SE
|
+$1.34B |
| 3 |
Morgan Stanley
MS
|
+$1.23B |
| 4 |
Incyte
INCY
|
+$1.05B |
| 5 |
Ross Stores
ROST
|
+$968M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$2.05B |
| 2 |
VMW
VMware, Inc
VMW
|
+$1.5B |
| 3 |
Visa
V
|
+$1.16B |
| 4 |
JPMorgan Chase
JPM
|
+$1.13B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.12B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.01% |
| 2 | Healthcare | 17.6% |
| 3 | Consumer Discretionary | 14.37% |
| 4 | Financials | 11.89% |
| 5 | Communication Services | 10.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2176
Geron
GERN
$982M
| $364K | ﹤0.01% |
166,897
-75,299
| -31% | -$113K |
|
2177
Red Rock Resorts
RRR
$3.67B
| $363K | ﹤0.01% |
33,251
-7,263
| -18% | -$82.1K |
|
2178
Invesco Mortgage Capital
IVR
$805M
| $361K | ﹤0.01% |
9,654
+1,903
| +25% | +$65.4K |
|
2179
Genesco
GCO
$394M
| $360K | ﹤0.01% |
16,601
-2
| -0% | -$37 |
|
2180
GameStop
GME
$8.33B
| $360K | ﹤0.01% |
332,076
-41,436
| -11% | -$47.8K |
|
2181
Macerich
MAC
$6.99B
| $357K | ﹤0.01% |
39,765
+8,773
| +28% | +$68K |
|
2182
Alaunos Therapeutics
TCRT
$4.86M
| $357K | ﹤0.01% |
725
+15
| +2% | +$6.69K |
|
|
CALA
2183
DELISTED
Calithera Biosciences, Inc
CALA
| $357K | ﹤0.01% |
3,382
-1,388
| -29% | -$165K |
|
|
ARR
2184
Armour Residential REIT
ARR
$2.37B
| $355K | ﹤0.01% |
7,566
+120
| +2% | +$5.03K |
|
|
HSKA
2185
DELISTED
Heska Corp
HSKA
| $355K | ﹤0.01% |
3,807
+15
| +0.4% | +$1.16K |
|
2186
Gorman-Rupp
GRC
$2.11B
| $353K | ﹤0.01% |
11,349
+27
| +0.2% | +$791 |
|
2187
Inseego
INSG
$77.7M
| $353K | ﹤0.01% |
3,042
-643
| -17% | -$68K |
|
2188
MYR Group
MYRG
$5.1B
| $353K | ﹤0.01% |
11,055
-9,600
| -46% | -$263K |
|
|
EGOV
2189
DELISTED
NIC Inc
EGOV
| $353K | ﹤0.01% |
15,369
-2,304
| -13% | -$54.5K |
|
2190
Stride
LRN
$3.48B
| $352K | ﹤0.01% |
12,921
+165
| +1% | +$3.97K |
|
|
AMAG
2191
DELISTED
AMAG Pharmaceuticals
AMAG
| $352K | ﹤0.01% |
46,022
-4,009
| -8% | -$30.7K |
|
2192
Hawthorn Bancshares
HWBK
$277M
| $351K | ﹤0.01% |
20,080
+118
| +0.6% | +$1.86K |
|
2193
iShares MSCI United Kingdom ETF
EWU
$4.13B
| $345K | ﹤0.01% |
13,400
-48,100
| -78% | -$1.22M |
|
2194
AAR Corp
AIR
$5.77B
| $344K | ﹤0.01% |
16,641
+179
| +1% | +$3.47K |
|
2195
Unisys
UIS
$210M
| $344K | ﹤0.01% |
31,566
-28,643
| -48% | -$331K |
|
2196
Metallus
MTUS
$892M
| $343K | ﹤0.01% |
88,157
+724
| +0.8% | +$2.42K |
|
2197
Agilysys
AGYS
$3.25B
| $342K | ﹤0.01% |
19,060
-7,020
| -27% | -$132K |
|
|
TBI
2198
Trueblue
TBI
$309M
| $340K | ﹤0.01% |
22,286
-94
| -0.4% | -$1.4K |
|
2199
Vishay Precision Group
VPG
$908M
| $340K | ﹤0.01% |
13,827
-5,064
| -27% | -$114K |
|
|
AHPI
2200
DELISTED
Allied Healthcare Products
AHPI
| $340K | ﹤0.01% |
28,900
+4,900
| +20% | +$58.3K |
|
Similar funds
T. Rowe Price Associates's Q2 2020 Portfolio in Review
As of Q2 2020, T. Rowe Price Associates held 2,591 positions worth $795B, up 26% from $632B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
T. Rowe Price Associates's Q2 2020 filing shows 79 new, 1,096 increased, 1,255 reduced and 100 closed positions. Its largest new stake was Vroom Inc: 200,362 shares worth $797M. The largest sale was Boeing, an estimated $2.05B.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2020 buy was Vroom Inc: 200,362 shares worth $797M.
- T. Rowe Price Associates added most to Microsoft in Q2 2020, an estimated $2B increase.
- T. Rowe Price Associates's biggest Q2 2020 reduction was Boeing, cutting an estimated $2.05B.
- T. Rowe Price Associates fully exited Raytheon Company in Q2 2020, selling an estimated $1.01B.
- T. Rowe Price Associates's ten largest holdings make up 25% of its $795B portfolio in Q2 2020.
- T. Rowe Price Associates opened 79 new positions and closed 100 in Q2 2020.
- T. Rowe Price Associates's portfolio value rose 26% quarter-over-quarter to $795B.
Based on T. Rowe Price Associates's 13F filing for Q2 2020, filed 14 Aug 2020.